| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $344K | — |
| Cost of Revenue | $197K | — |
| Gross Profit | -$3.0M | — |
| R&D Expense | $14.3M | +86.0% |
| SG&A Expense | $16.1M | +34.7% |
| Operating Income | -$47.8M | -121.4% |
| Net Income | -$52.5M | -146.0% |
| EPS (Basic) | -$1.02 | -108.2% |
| EPS (Diluted) | -$1.02 |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | +201.8% |
| Accounts Receivable | $228K | — |
| Inventory | $154K | +23.3% |
| Current Assets | $18.4M | +287.2% |
| Total Assets | $77.7M | +4.0% |
| Current Liabilities | $15.8M | +18.0% |
| Long-term Debt | $7.1M | — |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.7M | -25.2% |
| Investing Cash Flow | -$13.0M | +64.7% |
| Financing Cash Flow | $34.4M | +46.9% |
| -108.2% |
| Total Liabilities |
| $16.2M |
| +20.6% |
| Stockholders' Equity | $61.5M | +0.4% |